Accorda announces vice president appointment
Acorda Therapeutics Inc., the biopharmaceutical company in Hawthorne, said this morning that Dr. Anthony Caggiano has been promoted to vice president of preclinical development.
He will continue to manage the preclinical and research and development departments, the company said. He will also oversee the company’s preclinical programs that seek to develop treatments for multiple sclerosis, spinal cord injuries and other neurological disorders.
Caggiano joined the company in September 2001 as a laboratory scientist and has held a number of positions since then.